Clinical Trials Logo

Osteoarthritis, Knee clinical trials

View clinical trials related to Osteoarthritis, Knee.

Filter by:

NCT ID: NCT02950090 Completed - Clinical trials for Osteoarthritis, Knee

MobilWise: Mobile Phone Remote Coaching After Worksite Joint ADventure Exposure

Start date: September 2015
Phase: N/A
Study type: Interventional

MobilWise, a worksite physical activity intervention for employees at high risk for knee osteoarthritis (OA), is being tested in a developmental randomized controlled trial at a collaborating worksite to determine if remotely- coached physical activity counseling can increase and sustain physical activity in this population. Knee osteoarthritis is a major public health problem and a leading cause of disability and work absenteeism/presenteeism in the US workforce. The overarching goal of this program is to develop and disseminate an affordable, efficient, efficacious physical activity intervention to large groups of employees at risk for knee OA. The Mobil Wise intervention is administered by health professionals, who will use data transmitted from an affordable accelerometer-based personal monitor (Fitbit Flex) via customized remote coach interface to 1) allow the remote coach to view and collect physical activity data generated by the personal monitor, and 2) use that data to formulate and provide tailored behavioral support, using motivational interviewing. This project has the potential to have a tremendous impact on improving symptoms and quality of life of persons with chronic knee pain and decreasing the functional limitation, work absenteeism/presenteeism, and soaring healthcare utilization associated with knee OA.

NCT ID: NCT02949466 Not yet recruiting - Physical Activity Clinical Trials

Additional Effects of Triamcinolone to Hyaluronic Acid on Knee Osteoarthritis

Start date: October 2016
Phase: Phase 4
Study type: Interventional

Using a double-blind, randomized controlled design to investigate the additional therapeutic effects of 3 times of combined triamcinolone and hyaluronic acid injections to 3 times of hyaluronic acid injections to patients with knee osteoarthritis.

NCT ID: NCT02948218 Not yet recruiting - Knee Osteoarthritis Clinical Trials

Multi-center Clinical Research of Acupuncture Treatment of Knee Osteoarthritis

Start date: January 2017
Phase: Phase 3
Study type: Interventional

Knee osteoarthritis (KOA) is a major public health problem among the elderly and is associated with considerable disability. A recent analysis of data indicated that about 35% of women and men aged 60 years and above had radiographic knee OA.Despite the high prevalence rate of OA, the treatment of OA is far from satisfactory. Acupuncture may be a promising treatment option for knee OA due to the effectiveness of the pain relief and the rarity of adverse effects. In order to get some more reliable data to confirm acupuncture effectiveness on KOA, a long-term follow up interventional study will be started to confirm the effects of long term for acupuncture treatment.

NCT ID: NCT02947451 Completed - Knee Osteoarthritis Clinical Trials

Immediate Effects of Manual Therapy Versus TENS in Patients With Knee Osteoarthritis

Start date: November 2016
Phase: N/A
Study type: Interventional

Patients with knee Osteoarthritis have high prevalence of pain , requiring ever more precise interventions in their management. This study aims to investigate the immediate effects of manual therapy and TENS on pain in patients with knee Osteoarthritis. Knowledge of best interventions favors reducing spending on health and safety for the patient.

NCT ID: NCT02944448 Completed - Clinical trials for Osteoarthritis, Knee

A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee

Start date: September 2016
Phase: Phase 2
Study type: Interventional

The study schedule consists of a Screening Period (up to 14 days), a blinded 4- week Titration-to-Effect Period with weekly visits, a blinded 4-week Maintenance Treatment Period at the optimal dose level determined for each patient, and a 1-week Follow-up Period. Eligible patients will be randomized to receive either CR845 or placebo in a 2:1 ratio. Every patient will be started on a 1-mg dose of CR845 or matching placebo. During the post-randomization Titration-to-Effect period, the dose of study drug may be increased to 2.5 mg or 5 mg in a double-blind fashion. Patients may know their dose is being changed but will not know whether they were randomization to active study drug or placebo. Approximately 330 patients will be enrolled in this study.

NCT ID: NCT02934672 Completed - Clinical trials for Osteoarthritis of the Knee

KineSpring® System Patient Preference Study

Start date: June 2016
Phase:
Study type: Observational

The primary objectives of the survey are to obtain patient preference information that can be useful during the benefit-risk assessment of the KineSpring System.

NCT ID: NCT02934659 Completed - Clinical trials for Osteoarthritis, Knee

Atlas Knee System Clinical System Clinical Study (USA)

Atlas-USA
Start date: November 2016
Phase: N/A
Study type: Interventional

The primary objective of this pilot study is to collect data on the safety and effectiveness of the Atlas Knee System in subjects with medial knee osteoarthritis through 24 months postoperative follow-up.

NCT ID: NCT02931435 Completed - Clinical trials for Osteoarthritis, Knee

Radiofrequency For Chronic Knee Pain Post-Arthroplasty

DEFIANT
Start date: December 2016
Phase: N/A
Study type: Interventional

Chronic knee osteoarthritis (OA) is one of the most common diseases with increasing prevalence in advanced age. Knee OA results in movement restriction, sleep disturbance, and disability. Total knee arthroplasty (TKA) is employed often in the symptomatic treatment of knee OA. It has been estimated that 3.4 million TKAs will be performed in the year 2030 in the United States alone. Many studies report rewarding outcomes for patients, but other research shows there are many patients that remain dissatisfied post-arthroplasty. The purpose of this study is to evaluate whether genicular radiofrequency ablation can relieve chronic post-arthroplasty knee pain.

NCT ID: NCT02931383 Completed - Obesity Clinical Trials

Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance

US-LOSEIT-II
Start date: November 2016
Phase: Phase 4
Study type: Interventional

This is a substudy to a randomised trial investigating the effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis (OA) (NCT02905864). In the parent trial, patients will be subjected to an 8-week diet intervention phase including a low-calorie diet and dietetic counseling, after which patients will be randomised to receive either liraglutide 3 mg or liraglutide 3 mg placebo as an add-on to dietetic guidance on re-introducing regular foods and a focus on continued motivation to engage in a healthy lifestyle. This substudy aims to investigate the impact of, and subsequent change of, joint inflammation and clinical symptoms, in obese patients with knee osteoarthritis following a randomisation to Liraglutide 3 mg or Liraglutide 3 mg placebo treatment between weeks 0-52.

NCT ID: NCT02931370 Completed - Obesity Clinical Trials

Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss

US-LOSEIT-I
Start date: November 2016
Phase:
Study type: Observational

This is a substudy to a randomised trial investigating the effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis (NCT02905864). In the parent trial, patients will be subjected to an 8-week diet intervention phase including a low-calorie diet and dietetic counseling, after which patients will be randomised to receive either liraglutide 3 mg or liraglutide 3 mg placebo as an add-on to dietetic guidance on re-introducing regular foods and a focus on continued motivation to engage in a healthy lifestyle. This substudy aims to investigate any changes in Ultrasound (US) measures associated with the initial 8-week weight loss intervention.